Invesco S&P 500 Equal Weight Health Care ETF (RSPH) is a healthcare and biotech ETF. As of October 9, 2026, ETF Copilot scores RSPH 3.8 out of 10 — highest on Risk (7.2), lowest on Growth (1.3). It trades at 25.3 times earnings, against its own median of 24.3. Its ten largest holdings are 19% of the fund.
What stands out in RSPH's data
Equal-weight health care, covering the S&P 500's medical and biotech names.
Expected to grow earnings slower than most peers — the fund's stability comes at a cost to upside.
A forward growth estimate of 11% trails the category median of 20%, and its 22.8% EBITDA margin also falls short — the fund holds 60 stocks.
A sector bet that spreads exposure evenly across health care's largest names.
Why did RSPH move this week? It rose 2.6% in the week to October 9, 2026 — Moderna and Humana drove it
RSPH rose 2.6% in the week to October 9, 2026. The holdings that moved it most were Moderna (+18.4%), Humana (+11.2%) and Intuitive Surgical (+8.2%); Cooper (−4.5%) pushed the other way.
How is RSPH rated? ETF Copilot scores Invesco S&P 500 Equal Weight Health Care ETF (RSPH) 3.8 out of 10
As of October 9, 2026, ETF Copilot scores Invesco S&P 500 Equal Weight Health Care ETF (RSPH) 3.8 out of 10 overall.
ETF Copilot scores (0–10 scale, higher is better):
- Overall: 3.8 / 10
- Growth: 1.3 / 10
- Value: 4.6 / 10
- Risk: 7.2 / 10
- Quality: 3.7 / 10
- Return: 3.7 / 10
Is RSPH expensive right now? It trades at 25.3 times earnings, against its own median of 24.3
As of October 9, 2026, RSPH is more expensive than 63% of its own last 3 years.
Trailing 12 months, built from RSPH's holdings. How we calculate this →
What's inside RSPH?
What's inside RSPH: Size (Large 69%, Mid 31%, Small 0%); Geography (International 3%, US 97%); AI 0.8%.
What are RSPH's top holdings? The ten largest are 19% of the fund
Moderna, Illumina, Revvity, Mettler-Toledo International, Intuitive Surgical, Agilent Technologies, Veeva Systems, Abbvie, West Pharmaceutical Services and Thermo Fisher Scientific are RSPH's largest holdings, in that order.
Less concentrated than 91% of Health & Biotech ETFs.
Half of RSPH's weight sits in its 29 largest positions, and once those weights are taken into account it behaves like 59 equally weighted holdings.
What is RSPH's expense ratio? 0.40% a year
As of October 9, 2026, RSPH charges 0.40% a year, yields 0.59% and holds $875M in assets across 60 positions.
| Measure | RSPH |
|---|---|
| Expense ratio | 0.40% |
| Dividend yield | 0.59% |
| Assets under management | $875M |
| Holdings | 60 |
Expense ratio, dividend yield and assets under management are reported by the fund and refreshed daily. Every other figure on this page is computed by ETF Copilot.
Cite this
ETF Copilot, “Invesco S&P 500 Equal Weight Health Care ETF (RSPH) scores and holdings analysis”, as of October 9, 2026.
https://etf-copilot.com/etf/rsph
ETF Copilot Pro unlocks RSPH's price and what each holding weighs.
Try Pro free →